JD Health (06618.HK) CEO Cao Dong said at the China International Import Expo the company will sign agreements with more than 20 global pharmaceutical and health brands, including Pfizer, Merck, Novo Nordisk, Takeda, Boehringer Ingelheim, Novartis and Leo Pharma. Several partners have worked with JD Health for over a decade; the new deals expand cooperation beyond product launches and exclusive distribution to patient management and AI-driven innovations. JD Health says it now has deep partnersh

JD Health (06618.HK) CEO Cao Dong said at the China International Import Expo the company will sign agreements with more than 20 global pharmaceutical and health brands, including Pfizer, Merck, Novo Nordisk, Takeda, Boehringer Ingelheim, Novartis and Leo Pharma. Several partners have worked with JD Health for over a decade; the new deals expand cooperation beyond product launches and exclusive distribution to patient management and AI-driven innovations. JD Health says it now has deep partnerships with 50 of the world’s top multinationals, and has completed more than 100 online first launches of new drugs through Q3 2026, exceeding last year’s total.